Locked Out of a Cure? Only a Fraction of Early Alzheimer’s Patients Eligible for New Drugs Post author:Randy Banks Post published:October 8, 2023 Post category:News Only a small fraction of older adults with early Alzheimer’s symptoms are eligible for new monoclonal antibody treatments, according to a recent study. Full Story You Might Also Like Redressing stigma of Alzheimer’s September 9, 2024 Program Helps Alzheimer’s Caregivers Create Meaningful Moments September 24, 2023 Learning to live: Dementia brings ‘unofficial loss’ and often leads to grieving alone May 31, 2023
Only a small fraction of older adults with early Alzheimer’s symptoms are eligible for new monoclonal antibody treatments, according to a recent study. Full Story
